About Daxor Corp
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.daxor.com/
Frequently Asked Questions
What is the 52-week range for DXR?
The 52-week high is $14.76 and the 52-week low is $8.56.
What is the P/E ratio for DXR?
The Price to Earnings (P/E) ratio is 10.09.
What is the dividend yield for DXR?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 12.75%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 19861.42%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.59.
Analyst Recommendation Trends
Wall Street analyst consensus for DXR over the last few months:
Latest DXR News
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial Acceleration: Daxor to feature its FDA-cleared, next-generation Blood Volume Analyzer (BVA™) designed for rapid clinical adoption across hospital systems and outpatient clinicsClinical Evidence: Independent clinical investigators to present two ePosters highlighting how BVA addresses volume derangements
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Oak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City, New York on Thursday, September 10th, 2026. Management will host one-on-one and small group meetings with investors. For more information about the event or questions about registration, interested pa
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-28 | Jefferies John | +2,451 | - | - |
| 2026-06-23 | DesRosiers Caleb | +2,500 | - | - |
| 2026-06-23 | Goudie Joy S. | +2,500 | - | - |
| 2026-06-23 | Cremisi Henry D. | +2,500 | - | - |
| 2026-06-23 | Feldschuh Jonathan Adam | +25,000 | - | - |
| 2026-06-23 | Feuer Edward | +2,500 | - | - |
| 2026-06-23 | Feldschuh Michael Richard | +30,000 | - | - |
| 2026-06-23 | Michel Robert J | +12,000 | - | - |
| 2026-04-08 | Feldschuh Michael Richard | +1,000 | $9.07 | $9,070 |
| 2026-03-31 | Michel Robert J | +1,000 | $9.9 | $9,900 |
| 2026-03-20 | Jefferies John | +2,285 | - | - |
| 2026-03-20 | Jefferies John | +3,656 | - | - |
| 2025-12-09 | Feldschuh Jonathan Adam | +18,000 | - | - |
| 2025-12-09 | Michel Robert J | +3,000 | - | - |
| 2025-11-12 | Jefferies John | +2,344 | - | - |